Michael Brines
Oprichter bij Warren Pharmaceuticals, Inc.
Actieve functies van Michael Brines
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Warren Pharmaceuticals, Inc.
 Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY. | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 | - |
| Oprichter | 01-01-2001 | - | |
Araim Pharmaceuticals, Inc.
 Araim Pharmaceuticals, Inc. BiotechnologyHealth Technology Araim Pharmaceuticals, Inc. operates as a biotechnology company that develops novel treatments for devastating injuries and chronic diseases. It provides ARA 290, a novel 11 amino acid peptide that activates the body’s natural repair system through the innate repair receptor, which is present only following injury, as well as activates anti-inflammatory, tissue protective, and reparative signaling pathways. The company was founded by Anthony Cerami and Michael Brines in 2006 and is headquartered in Tarrytown, NY. | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 | - |
| Oprichter | 01-01-2006 | - |
Loopbaan van Michael Brines
Eerdere bekende functies van Michael Brines
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Yale University | Directeur/Bestuurslid | 01-01-1998 | 01-01-1998 |
Opleiding van Michael Brines
| The Rockefeller University | Doctorate Degree |
| University of Notre Dame | Undergraduate Degree |
| Yale University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Doctorate Degree | 2 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Warren Pharmaceuticals, Inc.
Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY. | Health Technology |
Araim Pharmaceuticals, Inc.
Araim Pharmaceuticals, Inc. BiotechnologyHealth Technology Araim Pharmaceuticals, Inc. operates as a biotechnology company that develops novel treatments for devastating injuries and chronic diseases. It provides ARA 290, a novel 11 amino acid peptide that activates the body’s natural repair system through the innate repair receptor, which is present only following injury, as well as activates anti-inflammatory, tissue protective, and reparative signaling pathways. The company was founded by Anthony Cerami and Michael Brines in 2006 and is headquartered in Tarrytown, NY. | Health Technology |
- Beurs
- Insiders
- Michael Brines
- Ervaring
